Need of fostering academic research for bridging the gap of “science- commerce disconnect” in ‘non-profitable’ therapy areas

2016-11-19T02-01-43Z
Source: International Journal of Basic & Clinical Pharmacology
Anant D. Patil, Tushar Balchand Chudiwal, Pratishtha Banga.
Pharmaceutical companies share the goal of patient benefit with healthcare professionals. However, they are commercial organizations and hence, sometimes, commercial interest may take over science, resulting in science-commercial disconnect. This can result in innovation-deficit and financial burden on the patients. Finding new indications for existing drugs and promoting academic research in non-profitable areas are some measures to curtail pharmaceutical innovation-deficit. Greater involvement of academicians and non-government organizations in clinical research with government support/funding will help in providing best treatment options to the patients for better outcomes.


http://ift.tt/2fOwtGF